Open-label randomized two-way crossover pilot study to estimate the effects of inhaled [Exubera] versus IV [intravenous] infusion of human insulin with regards to glucose disposal in subjects with type 1 diabetes mellitus.
Phase of Trial: Phase III
Latest Information Update: 20 Feb 2008
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Pfizer
- 14 Dec 2007 Status changed from completed to discontinued.
- 11 Apr 2007 Status changed from in progress to completed.
- 18 Jan 2007 Status changed from recruiting to in progress.